High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study

被引:243
作者
Asztalos, BF
Cupples, LA
Demissie, S
Horvath, KV
Cox, CE
Batista, MC
Schaefer, EJ
机构
[1] Tufts Univ, JM USDA HNRC, Lipid Metab Lab, HNRCA, Boston, MA 02111 USA
[2] Boston Univ, Dept Biostat, Boston, MA 02215 USA
关键词
lipoproteins; high-density lipoprotein cholesterol; high-density lipoprotein subpopulations; apolipoprotein; A-I; coronary heart disease;
D O I
10.1161/01.ATV.0000146325.93749.a8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - High-density lipoprotein (HDL) is a heterogeneous lipoprotein class and there is no consensus on the value of HDL subspecies in coronary heart disease (CHD) risk assessment. We tested the hypothesis whether specific HDL subpopulations are significantly associated with CHD-prevalence. Methods and Results - ApoA-I concentrations (mg/dL) in HDL subpopulations were quantitatively determined by native 2d gel electrophoresis, immunoblotting, and image analysis in male participants in the Framingham Offspring Study (FOS). CHD cases ( n = 169) had higher prebeta-1 and alpha-3 particle and lower alpha-1, prealpha-3, and prealpha-1 particle levels than either all ( n = 1277) or HDL cholesterol-matched ( n = 358) controls. alpha-1 and prealpha-3 levels had an inverse association, whereas alpha-3 and prealpha-1 particle levels had a positive association with CHD prevalence after adjusting the data for established CHD risk factors. Standardized logit coefficients indicated that alpha-1 HDL was most significantly associated with CHD prevalence. Moreover, each mg/dL increase in alpha-1 particle level decreased odds of CHD by 26% ( P < 0.0001), whereas each mg/dL increase in HDL cholesterol decreased odds of CHD by 2% in a model including all established CHD risk factors. Conclusions - Specific HDL subpopulations were positively correlated, whereas others were inversely correlated with CHD prevalence in male subject in the FOS, indicating that the various HDL particles might have different roles in the cause of CHD.
引用
收藏
页码:2181 / 2187
页数:7
相关论文
共 28 条
  • [1] Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations
    Asztalos, BF
    Lefevre, M
    Foster, TA
    Tulley, R
    Windhauser, M
    Wong, L
    Roheim, PS
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 1885 - 1893
  • [2] Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
    Asztalos, BF
    Horvath, KV
    McNamara, JR
    Roheim, PS
    Rubinstein, JJ
    Schaefer, EJ
    [J]. JOURNAL OF LIPID RESEARCH, 2002, 43 (10) : 1701 - 1707
  • [3] Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients
    Asztalos, BF
    Horvath, KV
    McNamara, JR
    Roheim, PS
    Rubinstein, JJ
    Schaefer, EJ
    [J]. ATHEROSCLEROSIS, 2002, 164 (02) : 361 - 369
  • [4] Change in α1 HDL concentration predicts progression in coronary artery stenosis
    Asztalos, BF
    Batista, M
    Horvath, KV
    Cox, CE
    Dallal, GE
    Morse, JS
    Brown, GB
    Schaefer, EJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : 847 - 852
  • [5] 2-DIMENSIONAL ELECTROPHORESIS OF PLASMA-LIPOPROTEINS - RECOGNITION OF NEW APO-A-I-CONTAINING SUBPOPULATIONS
    ASZTALOS, BF
    SLOOP, CH
    WONG, L
    ROHEIM, PS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1169 (03) : 291 - 300
  • [6] Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease
    Asztalos, BF
    Roheim, PS
    Milani, RL
    Lefevre, M
    McNamara, JR
    Horvath, KV
    Schaefer, EJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) : 2670 - 2676
  • [7] Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low HDL-cholesterol levels with or without primary hypertriglyceridemia
    Brites, FD
    Verona, J
    Schreier, LE
    Fruchart, JC
    Castro, GR
    Wikinski, RL
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2004, 35 (03) : 235 - 240
  • [8] DECREASED HDL2 AND HDL3 CHOLESTEROL, APO A-I AND APO A-II, AND INCREASED RISK OF MYOCARDIAL-INFARCTION
    BURING, JE
    OCONNOR, GT
    GOLDHABER, SZ
    ROSNER, B
    HERBERT, PN
    BLUM, CB
    BRESLOW, JL
    HENNEKENS, CH
    [J]. CIRCULATION, 1992, 85 (01) : 22 - 29
  • [9] EARLY INCORPORATION OF CELL-DERIVED CHOLESTEROL INTO PRE-BETA-MIGRATING HIGH-DENSITY LIPOPROTEIN
    CASTRO, GR
    FIELDING, CJ
    [J]. BIOCHEMISTRY, 1988, 27 (01) : 25 - 29
  • [10] Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL
    Cheung, MC
    Zhao, XQ
    Chait, A
    Albers, JJ
    Brown, BG
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) : 1320 - 1326